Skip Nav Destination
Issues
Neurodegenerative Diseases 2014, Vol. 13, No. 2-3
Title Page / Table of Contents
Neurodegener Dis (2014) 13 (2-3): 53–56.
https://doi.org/10.1159/000358281
Sustained Alzheimer's Amyloid Pathology in Myeloid Differentiation Protein-88-Deficient APPswe/PS1 Mice
Neurodegener Dis (2014) 13 (2-3): 58–60.
https://doi.org/10.1159/000353689
Function and Dysfunction of Presenilin
Neurodegener Dis (2014) 13 (2-3): 61–63.
https://doi.org/10.1159/000354971
The E280A Presenilin Mutation Reduces Voltage-Gated Sodium Channel Levels in Neuronal Cells
Neurodegener Dis (2014) 13 (2-3): 64–68.
https://doi.org/10.1159/000354669
Parkin Plays a Role in Sporadic Parkinson's Disease
Neurodegener Dis (2014) 13 (2-3): 69–71.
https://doi.org/10.1159/000354307
ADAM10 in Synaptic Physiology and Pathology
Neurodegener Dis (2014) 13 (2-3): 72–74.
https://doi.org/10.1159/000354233
Impact of Vitamin D on Amyloid Precursor Protein Processing and Amyloid-β Peptide Degradation in Alzheimer's Disease
Marcus O.W. Grimm; Johannes Lehmann; Janine Mett; Valerie C. Zimmer; Sven Grösgen; Christoph P. Stahlmann; Benjamin Hundsdörfer; Viola J. Haupenthal; Tatjana L. Rothhaar; Christian Herr; Robert Bals; Heike S. Grimm; Tobias Hartmann
Neurodegener Dis (2014) 13 (2-3): 75–81.
https://doi.org/10.1159/000355462
Possible Role of Dynorphins in Alzheimer's Disease and Age-Related Cognitive Deficits
Neurodegener Dis (2014) 13 (2-3): 82–85.
https://doi.org/10.1159/000353848
Hippocampus-Related Cognitive Impairments in Young apoE4 Targeted Replacement Mice
Neurodegener Dis (2014) 13 (2-3): 86–92.
https://doi.org/10.1159/000354777
Cytoskeletal Protection: Acting on Notch to Prevent Neuronal Dysfunction
Sara Anna Bonini; Giulia Ferrari-Toninelli; Giuseppina Maccarinelli; Paola Bettinsoli; Mery Montinaro; Maurizio Memo
Neurodegener Dis (2014) 13 (2-3): 93–95.
https://doi.org/10.1159/000354230
β-Amyloid Precursor Protein: Function in Stem Cell Development and Alzheimer's Disease Brain
Neurodegener Dis (2014) 13 (2-3): 96–98.
https://doi.org/10.1159/000353686
The Therapeutic Effects of Human Adipose-Derived Stem Cells in Alzheimer's Disease Mouse Models
Neurodegener Dis (2014) 13 (2-3): 99–102.
https://doi.org/10.1159/000355261
Tau Immunotherapy and Imaging
Neurodegener Dis (2014) 13 (2-3): 103–106.
https://doi.org/10.1159/000354491
Inhibition of Amyloid Precursor Protein Processing Leads to Downregulation of Apoptotic Genes in Alzheimer's Disease Animal Models
Neurodegener Dis (2014) 13 (2-3): 107–109.
https://doi.org/10.1159/000353749
Regulation of Autophagy by LRRK2 in Caenorhabditis elegans
Neurodegener Dis (2014) 13 (2-3): 110–113.
https://doi.org/10.1159/000355654
Defining the Native State of α-Synuclein
Neurodegener Dis (2014) 13 (2-3): 114–117.
https://doi.org/10.1159/000355516
Interplay between Parkin and p53 Governs a Physiological Homeostasis That Is Disrupted in Parkinson's Disease and Cerebral Cancer
Neurodegener Dis (2014) 13 (2-3): 118–121.
https://doi.org/10.1159/000354075
Allelic Interference: A Mechanism for Trans-Dominant Transmission of Loss of Function in the Neurodegeneration of Familial Alzheimer's Disease
Neurodegener Dis (2014) 13 (2-3): 126–130.
https://doi.org/10.1159/000354241
Stress Impairs Synaptic Plasticity in Triple-Transgenic Alzheimer's Disease Mice: Rescue by Ryanodine
Neurodegener Dis (2014) 13 (2-3): 135–138.
https://doi.org/10.1159/000354231
Can the Calcium Hypothesis Explain Synaptic Loss in Alzheimer's Disease?
Neurodegener Dis (2014) 13 (2-3): 139–141.
https://doi.org/10.1159/000354778
The Inside-Out Amyloid Hypothesis and Synapse Pathology in Alzheimer's Disease
Neurodegener Dis (2014) 13 (2-3): 142–146.
https://doi.org/10.1159/000354776
We Can Treat Alzheimer's Disease Successfully in Mice but Not in Men: Failure in Translation? A Perspective
Neurodegener Dis (2014) 13 (2-3): 147–150.
https://doi.org/10.1159/000357568
Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease
Neurodegener Dis (2014) 13 (2-3): 151–153.
https://doi.org/10.1159/000353687
The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia
Yaroslau Compta; Laura Parkkinen; Peter Kempster; Mariana Selikhova; Tammaryn Lashley; Janice L. Holton; Andrew J. Lees; Tamas Revesz
Neurodegener Dis (2014) 13 (2-3): 154–156.
https://doi.org/10.1159/000354670
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects
Camilla Ferrari; Benedetta Nacmias; Silvia Bagnoli; Irene Piaceri; Gemma Lombardi; Silvia Pradella; Andrea Tedde; Sandro Sorbi
Neurodegener Dis (2014) 13 (2-3): 157–159.
https://doi.org/10.1159/000353690
Molecular Imaging in Sporadic Alzheimer's Disease Populations and Those Genetically at Risk
Neurodegener Dis (2014) 13 (2-3): 160–162.
https://doi.org/10.1159/000356333
Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms
R.S. Osorio; E. Pirraglia; T. Gumb; J. Mantua; I. Ayappa; S. Williams; L. Mosconi; L. Glodzik; M.J. de Leon
Neurodegener Dis (2014) 13 (2-3): 163–165.
https://doi.org/10.1159/000355063
Relative Ratio and Level of Amyloid-β 42 Surrogate in Cerebrospinal Fluid of Familial Alzheimer Disease Patients with Presenilin 1 Mutations
Shinji Tagami; Masayasu Okochi; Kanta Yanagida; Takashi Kodama; Tetsuaki Arai; Ryozo Kuwano; Takeshi Ikeuchi; Masatoshi Takeda
Neurodegener Dis (2014) 13 (2-3): 166–170.
https://doi.org/10.1159/000355258
The Neuroprotection Exerted by Memantine, Minocycline and Lithium, against Neurotoxicity of CSF from Patients with Amyotrophic Lateral Sclerosis, Is Antagonized by Riluzole
Matilde Yáñez; Jorge Matías-Guiu; Juan-Alberto Arranz-Tagarro; Lucía Galán; Dolores Viña; Ulises Gómez-Pinedo; Álvaro Vela; Antonio Guerrero; Eduardo Martínez-Vila; Antonio G. García
Neurodegener Dis (2014) 13 (2-3): 171–179.
https://doi.org/10.1159/000357281
Familial Progressive Supranuclear Palsy: A Literature Review
Neurodegener Dis (2014) 13 (2-3): 180–182.
https://doi.org/10.1159/000354975
Neuroinflammatory Phenotypes and Their Roles in Alzheimer's Disease
Neurodegener Dis (2014) 13 (2-3): 183–185.
https://doi.org/10.1159/000354228
Resting-State Networks in Alzheimer's Disease and Parkinson's Disease
Neurodegener Dis (2014) 13 (2-3): 186–188.
https://doi.org/10.1159/000354237
MRI for Iron Mapping in Alzheimer's Disease
Neurodegener Dis (2014) 13 (2-3): 189–191.
https://doi.org/10.1159/000353756
Effect of Donepezil in Alzheimer Disease Can Be Measured by a Computerized Human Analog of the Morris Water Maze
J. Hort; R. Andel; I. Mokrisova; I. Gazova; J. Amlerova; M. Valis; E.J. Coulson; J. Harrison; M. Windisch; J. Laczó
Neurodegener Dis (2014) 13 (2-3): 192–196.
https://doi.org/10.1159/000355517
Comparing Predictors of Conversion to Alzheimer's Disease Using the Disease State Index
Miguel Ángel Muñoz-Ruiz; Anette Hall; Jussi Mattila; Juha Koikkalainen; Sanna-Kaisa Herukka; Ritva Vanninen; Yawu Liu; Jyrki Lötjönen; Hilkka Soininen; Alzheimer's Disease Neuroimaging Initiative
Neurodegener Dis (2014) 13 (2-3): 200–202.
https://doi.org/10.1159/000354074
Author Index Vol. 13, No. 2-3, 2014
Neurodegener Dis (2014) 13 (2-3): 203.
https://doi.org/10.1159/000358282
Subject Index Vol. 13, No. 2-3, 2014
Neurodegener Dis (2014) 13 (2-3): 204.
https://doi.org/10.1159/000358283
